FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/03/012602 [Registered on: 15/03/2018] Trial Registered Prospectively
Last Modified On: 12/03/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   A CLINICAL TRIAL TO STUDY THE EFFECTS OF HYPERBARIC BUPIVACAINE AND FENTANYL DRUGS GIVEN EITHER AS A MIXTURE OR SEQUENTIALLY FOR SPINAL ANAESTHESIA IN PATIENTS UNDERGOING CAESAREAN SECTION 
Scientific Title of Study   COMPARATIVE STUDY OF HYPERBARIC BUPIVACAINE AND FENTANYL GIVEN EITHER AS A MIXTURE OR SEQUENTIALLY FOR SUBARACHNOID BLOCK IN PATIENTS UNDERGOING CAESAREAN SECTION 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
2017048  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rahul Kalshan 
Designation  Post Graduate Student 
Affiliation  Vardhman Mahavir Medical College 
Address  Department of Anaesthesiology and intensive care,Ground floor,Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital,New Delhi 110029

South West
DELHI
110029
India 
Phone  8010886902  
Fax    
Email  rahul.kalshans@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ranju Gandhi 
Designation  Professor 
Affiliation  Vardhman Mahavir Medical College 
Address  Department of Anaesthesiology and intensive care,Ground floor,Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital,New Delhi 110029

South West
DELHI
110029
India 
Phone  9818941341  
Fax    
Email  icu_era@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Rahul Kalshan 
Designation  Post Graduate Student 
Affiliation  Vardhman Mahavir Medical College 
Address  Department of Anaesthesiology and intensive care,Ground floor,Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital,New Delhi 110029
Department of Anaesthesiology and intensive care,Ground floor,Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital,New Delhi 110029
South West
DELHI
110029
India 
Phone  9818941341  
Fax    
Email  rahul.kalshans@gmail.com  
 
Source of Monetary or Material Support  
Vardhman Mahavir Medical College and Safdarjung Hospital New Delhi 110029 INDIA 
 
Primary Sponsor  
Name  Vardhman Mahavir Medical College 
Address  Ansari Nagar, New Delhi 110029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Ranju Gandhi  Ansari Nagar, New Delhi 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rahul Kalshan  Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029  Department of Anaesthesiology and intensive care,Ground floor,Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital,New Delhi 110029
South West
DELHI 
8010886902

rahul.kalshans@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTE ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Adult ASA I,II parturients with height 145-165 cm and Body mass index 35 kg/m2,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Mixed group   Patients in this group will be given 0.5% hyperbaric bupivacaine 9 mg and fentanyl 15 mcg in a 5 ml syringe at a speed of 0.1 ml/sec in the sub arachnoid space by 25 Gauze spinal needle 
Intervention  Sequential Group  Patients in this group will be given 0.5% hyperbaric bupivacaine 9 mg in a 5 ml syringe followed by fentanyl 15 mcg in a 1 ml syringe at a speed of 0.1 ml/sec in the sub arachnoid space by 25 Gauze spinal needle 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Adult ASA physical status I, II with height 145-165 cm and Body mass index (BMI) < 35 kg/m2 
 
ExclusionCriteria 
Details  Known coagulation abnormality or bleeding diathesis, local infection at the site of spinal injection, raised intracranial tension, chronic hypertension, severe hypotension, hypovolaemia, cord prolapse, hypersensitivity to local anaesthetic or fentanyl. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of hyperbaric bupivacaine and fentanyl given either as a mixture or sequentially for subarachnoid block in terms of 1) Block characteristics, 2) Haemodynamic parameters 3) Time required to achieve sensory block height (T5) for caesarean section.  Before giving surgical incision 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the duration of sensory and motor block, total dose of vasopressor and neonatal outcome as assessed by Umbilical cord blood gas analysis, Apgar Score and need for Neonatal Resuscitation in above patients  at the time of giving subarachnoid block, during surgery and post operative period 
 
Target Sample Size   Total Sample Size="180"
Sample Size from India="180" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/04/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   1)Xiao F, Xu WP, Zhang XM, Zhang YF, Wang LZ, Chen XZ. ED 50 and ED 95 of Intrathecal Bupivacaine Coadministered with Sufentanil for Cesarean Delivery Under Combined Spinal-epidural in Severely Preeclamptic Patients. Chin Med J 2015;128:285-90. 2) Desai S, Lim Y, Tan CH, Sia AT. A randomised controlled trial of hyperbaric bupivacaine with opioids, injected as either a mixture or sequentially, for spinal anaesthesia for caesarean section. Anaesth Intensive Care 2010;38:280-4. 3) Keera AA, Elnabtity AM. Two syringe spinal anesthesia technique for cesarean section: A controlled randomized study of a simple way to achieve more satisfactory block and less hypotension. Anesth Essays Res 2016;10:312-8. 4) Sachan P, Kumar N, Sharma JP. Efficacy of premixed versus sequential administration of clonidine as an adjuvant to hyperbaric bupivacaine intrathecally in caesarean section. Anesthesia, Essays and Researches. 2014;8(1):20-5  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   comparison of hyperbaric bupivacaine and fentanyl injected intrathecally either by single syringe or different syringes sequentially .
 
 
Close